Acetaminophen And Codeine
NDC 33261-002
Product Information
Acetaminophen And Codeine is a ANDA-approved product labeled by Aidarex Pharmaceuticals Llc. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a white product. This product entry covers the primary NDC 33261-002 and 13 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
12 MM
2064;V;3
2065;V;4
Code Structure Chart
Product Details
What is NDC 33261-002?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- CODEINE PHOSPHATE (UNII: GSL05Y1MN6)
- CODEINE ANHYDROUS (UNII: UX6OWY2V7J) (Active Moiety)
- ACETAMINOPHEN (UNII: 362O9ITL9D)
- ACETAMINOPHEN (UNII: 362O9ITL9D) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- POVIDONES (UNII: FZ989GH94E)
- STARCH, CORN (UNII: O8232NY3SJ)
- SODIUM METABISULFITE (UNII: 4VON5FNS3C)
- SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)
- STEARIC ACID (UNII: 4ELV7Z65AP)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 993781 - codeine phosphate 30 MG / acetaminophen 300 MG Oral Tablet
- RxCUI: 993781 - acetaminophen 300 MG / codeine phosphate 30 MG Oral Tablet
- RxCUI: 993781 - APAP 300 MG / codeine phosphate 30 MG Oral Tablet
- RxCUI: 993890 - codeine phosphate 60 MG / acetaminophen 300 MG Oral Tablet
- RxCUI: 993890 - acetaminophen 300 MG / codeine phosphate 60 MG Oral Tablet
* Please review the full disclaimer at the bottom of this page.